Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy

Steven L. Valenstein, Walter Voigt, Charles Vogel, Sharon Thomsen, Everett V. Sugarbaker, Albert Castro, Vicram Gupta, Komanduri Charyulu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The present retrospective analysis was done to determine whether previous radiotherapy to a biopsy site could be a source of false-negative estrogen receptor assays as suggested in earlier reports. The present study population included 56 women who had estrogen receptor assays done on tumor tissue obtained from skin, subcutaneous, or lymph node metastases. Tissue was taken from a previously irradiated area in 14 patients and from an unirradiated area in 42. Fifty-seven percent of the former and 50% of the latter patients had positive estrogen receptor assays, and quantitative levels of estrogen receptor also were comparable between the two populations. Other potential variables, including age, menopausal status, disease-free interval, dominant metastatic site, prior cytotoxic chemotherapy, and extent of disease, also were analyzed, but did not significantly alter interpretation of results. Patients in both irradiated and unirradiated groups who had low tumor-to-stroma ratios histopathologically were less likely to have positive estradiol receptor assays than patients with more cellular tumors (25% vs. 70%). In the present series it did not appear that prior radiotherapy to a site biopsied for estrogen receptor assay resulted in false-negative determinations. These observations require confirmation in large comparative series of patients.

Original languageEnglish
Pages (from-to)617-623
Number of pages7
JournalSurgery
Volume85
Issue number6
StatePublished - Jan 1 1979

Fingerprint

Estrogen Receptors
Radiotherapy
Neoplasms
Estradiol Receptors
Population
Lymph Nodes
Neoplasm Metastasis
Biopsy
Drug Therapy
Skin

ASJC Scopus subject areas

  • Surgery

Cite this

Valenstein, S. L., Voigt, W., Vogel, C., Thomsen, S., Sugarbaker, E. V., Castro, A., ... Charyulu, K. (1979). Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy. Surgery, 85(6), 617-623.

Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy. / Valenstein, Steven L.; Voigt, Walter; Vogel, Charles; Thomsen, Sharon; Sugarbaker, Everett V.; Castro, Albert; Gupta, Vicram; Charyulu, Komanduri.

In: Surgery, Vol. 85, No. 6, 01.01.1979, p. 617-623.

Research output: Contribution to journalArticle

Valenstein, SL, Voigt, W, Vogel, C, Thomsen, S, Sugarbaker, EV, Castro, A, Gupta, V & Charyulu, K 1979, 'Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy', Surgery, vol. 85, no. 6, pp. 617-623.
Valenstein, Steven L. ; Voigt, Walter ; Vogel, Charles ; Thomsen, Sharon ; Sugarbaker, Everett V. ; Castro, Albert ; Gupta, Vicram ; Charyulu, Komanduri. / Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy. In: Surgery. 1979 ; Vol. 85, No. 6. pp. 617-623.
@article{36779f326fe544d78b0bc21170782ed9,
title = "Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy",
abstract = "The present retrospective analysis was done to determine whether previous radiotherapy to a biopsy site could be a source of false-negative estrogen receptor assays as suggested in earlier reports. The present study population included 56 women who had estrogen receptor assays done on tumor tissue obtained from skin, subcutaneous, or lymph node metastases. Tissue was taken from a previously irradiated area in 14 patients and from an unirradiated area in 42. Fifty-seven percent of the former and 50{\%} of the latter patients had positive estrogen receptor assays, and quantitative levels of estrogen receptor also were comparable between the two populations. Other potential variables, including age, menopausal status, disease-free interval, dominant metastatic site, prior cytotoxic chemotherapy, and extent of disease, also were analyzed, but did not significantly alter interpretation of results. Patients in both irradiated and unirradiated groups who had low tumor-to-stroma ratios histopathologically were less likely to have positive estradiol receptor assays than patients with more cellular tumors (25{\%} vs. 70{\%}). In the present series it did not appear that prior radiotherapy to a site biopsied for estrogen receptor assay resulted in false-negative determinations. These observations require confirmation in large comparative series of patients.",
author = "Valenstein, {Steven L.} and Walter Voigt and Charles Vogel and Sharon Thomsen and Sugarbaker, {Everett V.} and Albert Castro and Vicram Gupta and Komanduri Charyulu",
year = "1979",
month = "1",
day = "1",
language = "English",
volume = "85",
pages = "617--623",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy

AU - Valenstein, Steven L.

AU - Voigt, Walter

AU - Vogel, Charles

AU - Thomsen, Sharon

AU - Sugarbaker, Everett V.

AU - Castro, Albert

AU - Gupta, Vicram

AU - Charyulu, Komanduri

PY - 1979/1/1

Y1 - 1979/1/1

N2 - The present retrospective analysis was done to determine whether previous radiotherapy to a biopsy site could be a source of false-negative estrogen receptor assays as suggested in earlier reports. The present study population included 56 women who had estrogen receptor assays done on tumor tissue obtained from skin, subcutaneous, or lymph node metastases. Tissue was taken from a previously irradiated area in 14 patients and from an unirradiated area in 42. Fifty-seven percent of the former and 50% of the latter patients had positive estrogen receptor assays, and quantitative levels of estrogen receptor also were comparable between the two populations. Other potential variables, including age, menopausal status, disease-free interval, dominant metastatic site, prior cytotoxic chemotherapy, and extent of disease, also were analyzed, but did not significantly alter interpretation of results. Patients in both irradiated and unirradiated groups who had low tumor-to-stroma ratios histopathologically were less likely to have positive estradiol receptor assays than patients with more cellular tumors (25% vs. 70%). In the present series it did not appear that prior radiotherapy to a site biopsied for estrogen receptor assay resulted in false-negative determinations. These observations require confirmation in large comparative series of patients.

AB - The present retrospective analysis was done to determine whether previous radiotherapy to a biopsy site could be a source of false-negative estrogen receptor assays as suggested in earlier reports. The present study population included 56 women who had estrogen receptor assays done on tumor tissue obtained from skin, subcutaneous, or lymph node metastases. Tissue was taken from a previously irradiated area in 14 patients and from an unirradiated area in 42. Fifty-seven percent of the former and 50% of the latter patients had positive estrogen receptor assays, and quantitative levels of estrogen receptor also were comparable between the two populations. Other potential variables, including age, menopausal status, disease-free interval, dominant metastatic site, prior cytotoxic chemotherapy, and extent of disease, also were analyzed, but did not significantly alter interpretation of results. Patients in both irradiated and unirradiated groups who had low tumor-to-stroma ratios histopathologically were less likely to have positive estradiol receptor assays than patients with more cellular tumors (25% vs. 70%). In the present series it did not appear that prior radiotherapy to a site biopsied for estrogen receptor assay resulted in false-negative determinations. These observations require confirmation in large comparative series of patients.

UR - http://www.scopus.com/inward/record.url?scp=0018569967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018569967&partnerID=8YFLogxK

M3 - Article

C2 - 451871

AN - SCOPUS:0018569967

VL - 85

SP - 617

EP - 623

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -